0001209191-22-054486.txt : 20221025
0001209191-22-054486.hdr.sgml : 20221025
20221025160015
ACCESSION NUMBER: 0001209191-22-054486
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20221024
FILED AS OF DATE: 20221025
DATE AS OF CHANGE: 20221025
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Carter Martha J.
CENTRAL INDEX KEY: 0001213040
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-33451
FILM NUMBER: 221329490
MAIL ADDRESS:
STREET 1: C/O AEGERION PHARMACEUTICALS, INC.
STREET 2: 89 HEADQUARTERS PLAZA, SUITE 1212
CITY: MORRISTOWN
STATE: NJ
ZIP: 07960
FORMER NAME:
FORMER CONFORMED NAME: CARTER MARTHA J
DATE OF NAME CHANGE: 20030106
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: ALBIREO PHARMA, INC.
CENTRAL INDEX KEY: 0001322505
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 10 POST OFFICE SQUARE
STREET 2: SUITE 502 SOUTH
CITY: BOSTON
STATE: MA
ZIP: 02109
BUSINESS PHONE: 857-415-4774
MAIL ADDRESS:
STREET 1: 10 POST OFFICE SQUARE
STREET 2: SUITE 502 SOUTH
CITY: BOSTON
STATE: MA
ZIP: 02109
FORMER COMPANY:
FORMER CONFORMED NAME: Biodel Inc
DATE OF NAME CHANGE: 20050331
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2022-10-24
0
0001322505
ALBIREO PHARMA, INC.
ALBO
0001213040
Carter Martha J.
C/O ALBIREO PHARMA, INC.
53 STATE STREET, 19TH FLOOR
BOSTON
MA
02109
0
1
0
0
Chief Regulatory Officer
Common Stock
2022-10-24
4
S
0
104
19.5764
D
15564
D
Shares sold pursuant to a Rule 10b5-1 arrangement established in October 2019 to satisfy tax obligations arising out of the vesting of previously granted restricted stock units.
Represents 1,670 shares of common stock and 13,894 restricted stock units.
/s/ Jason Duncan, Attorney-in-fact
2022-10-25